SCHEMBL5229864

SCHEMBL5229864

O=C1NC(=O)C(n2ccnc2)=C1c1c[nH]c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CAMK2D Q13557 6/20 0.59
▸ PRKCB P05771 3/20 0.59
▸ CCNE2 O96020 2/20 0.59
▸ CDK4 P11802 2/20 0.59
▸ PRKACA P17612 2/20 0.59
▸ PRKACG P22612 2/20 0.59
▸ PRKACB P22694 2/20 0.59
▸ CCND1 P24385 2/20 0.59
▸ CCNE1 P24864 2/20 0.59
▸ CDK2 P24941 2/20 0.59
▸ PRKCA P17252 2/20 0.59
▸ PRKD3 O94806 1/20 0.59
▸ CCNB2 O95067 1/20 0.59
▸ ABL1 P00519 1/20 0.59
▸ PRKCG P05129 1/20 0.59
▸ CDK1 P06493 1/20 0.59
▸ PIM1 P11309 1/20 0.59
▸ CCNB1 P14635 1/20 0.59
▸ PRKCH P24723 1/20 0.59
▸ PRKCI P41743 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5682674 0.81 SIRT2 (0.64) CAMK2DPRKCBCCNE2CDK4PRKACA
Ro-316233 SCHEMBL624896 0.77 PRKCB (1.00) CAMK2DPRKCBCCNE2CDK4PRKACA
Ro-316233 SCHEMBL29373011 0.77 PRKCB (1.00) CAMK2DPRKCBCCNE2CDK4PRKACA
SCHEMBL13917970 0.76 PRKCB (0.78) CAMK2DPRKCBCCNE2CDK4PRKACA
SCHEMBL27827559 0.74 MEN1 (0.51) SIRT2GSK3BQPCT
SCHEMBL5686122 0.74 GSK3B (0.74) CAMK2DPRKCBCCNE2CDK4PRKACA
SCHEMBL5946249 0.73 GSK3B (0.71) CAMK2DPRKCBCCNE2CDK4PRKACA
SCHEMBL9464864 0.71 MEN1 (0.54) PIM1
SCHEMBL7003063 0.71 PRKCB (0.63) CAMK2DPRKCBCCNE2CDK4PRKACA
SCHEMBL13596802 0.70 PRKCB (0.72) CAMK2DPRKCBCCNE2CDK4PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070068-B2 GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT UNIV BRITISH COLUMBIA (CA) 2007-01-17 — — EP disclosed
EP-1070068-B1 GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT UNIV BRITISH COLUMBIA (CA) 2003-10-08 — — EP disclosed
US-6291447-B1 INHIBITING THE G2 CHECKPOINT IN A CELL THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2001-09-18 — — US disclosed
EP-1070068-A1 GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2001-01-24 — — EP disclosed
WO-1999047522-A1 GRANULATIMIDE DERIVATIVES FOR USE IN CANCER TREATMENT THE UNIVERSITY OF BRITISH COLUMBIA (CA) 1999-09-23 — — WO disclosed
Send feedback